| Stage | CTAS | % of rev | UNF | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.0B | 100.00% | $645M | 100.00% | CTAS ×4.67 |
| Gross profit | $1.6B | 51.54% | $241M | 37.38% | CTAS +14.2pp |
| Operating income | $712M | 23.62% | $42M | 6.46% | CTAS +17.2pp |
| Pre-tax income | $690M | 22.89% | $43M | 6.71% | CTAS +16.2pp |
| Net income | $552M | 18.31% | $35M | 5.38% | CTAS +12.9pp |
| Stage | CTAS | UNF | Gap · A − B |
|---|---|---|---|
| Revenue | $3.0B100.00% | $645M100.00% | CTAS ×4.67 |
| Gross profit | 51.54%$1.6B | 37.38%$241M | CTAS +14.2pp |
| Operating income | 23.62%$712M | 6.46%$42M | CTAS +17.2pp |
| Pre-tax income | 22.89%$690M | 6.71%$43M | CTAS +16.2pp |
| Net income |
| 18.31%$552M |
| 5.38%$35M |
| CTAS +12.9pp |
No disclosed counterparties: CTAS, UNF.